1. Home
  2. VVOS vs RLYB Comparison

VVOS vs RLYB Comparison

Compare VVOS & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • RLYB
  • Stock Information
  • Founded
  • VVOS 2016
  • RLYB 2018
  • Country
  • VVOS United States
  • RLYB United States
  • Employees
  • VVOS N/A
  • RLYB N/A
  • Industry
  • VVOS Medical Specialities
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • RLYB Health Care
  • Exchange
  • VVOS Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • VVOS 27.3M
  • RLYB 24.1M
  • IPO Year
  • VVOS 2020
  • RLYB 2021
  • Fundamental
  • Price
  • VVOS $2.89
  • RLYB $0.54
  • Analyst Decision
  • VVOS Strong Buy
  • RLYB Hold
  • Analyst Count
  • VVOS 2
  • RLYB 2
  • Target Price
  • VVOS $6.25
  • RLYB N/A
  • AVG Volume (30 Days)
  • VVOS 269.2K
  • RLYB 342.0K
  • Earning Date
  • VVOS 11-13-2025
  • RLYB 11-06-2025
  • Dividend Yield
  • VVOS N/A
  • RLYB N/A
  • EPS Growth
  • VVOS N/A
  • RLYB N/A
  • EPS
  • VVOS N/A
  • RLYB N/A
  • Revenue
  • VVOS $14,393,000.00
  • RLYB $761,000.00
  • Revenue This Year
  • VVOS $16.05
  • RLYB N/A
  • Revenue Next Year
  • VVOS $43.75
  • RLYB N/A
  • P/E Ratio
  • VVOS N/A
  • RLYB N/A
  • Revenue Growth
  • VVOS 2.65
  • RLYB 154.51
  • 52 Week Low
  • VVOS $1.98
  • RLYB $0.22
  • 52 Week High
  • VVOS $7.95
  • RLYB $1.24
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 33.05
  • RLYB 48.66
  • Support Level
  • VVOS $3.02
  • RLYB $0.49
  • Resistance Level
  • VVOS $3.28
  • RLYB $0.60
  • Average True Range (ATR)
  • VVOS 0.24
  • RLYB 0.04
  • MACD
  • VVOS 0.02
  • RLYB -0.00
  • Stochastic Oscillator
  • VVOS 9.84
  • RLYB 53.02

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: